Infectious Disease In Vitro Diagnostics Market by Product (Reagents, Instruments), Technology (Microbiology, Molecular Diagnostics), Application (VRE, MRSA), Test Location (Central Laboratories, Point of Care), and by Region - Global Forecast to 2022-2033

The infectious disease in vitro diagnostics market size is estimated to be USD 113,752.1 million in 2022 and is expected to witness a CAGR of 7.55% during the forecast period 2023-2033. Increasing elderly population that are more susceptible to infectious diseases, rising demand for PoC testing due to the pandemic, the improved understanding of early testing, and surge in prevalence of infectious diseases are factors contributing to the market growth. Additionally, shift from centralised laboratories to decentralised point-of-care services is expected to propel the market growth. However, is expected to hinder the growth.

Shift from centralised laboratories to decentralised point-of-care services is predicted to fuel the market growth. POC testing helps in early identification and treatment of a number of infectious disorders, including Chlamydia, gonorrhoea, and influenza, among others. POC testing in a decentralised system helps patients and doctors keep a record of infectious diseases and enhances clinical efficiency. Point-of-care (POC) testing is frequently carried out for diagnosis at or close to the location where a patient first interacts with the healthcare system. POC tests may enhance the way infectious illness patients are managed.

Increasing elderly population that are more susceptible to infectious diseases is expected to support the market growth. As ageing is the primary risk factor for the emergence of diseases including cardiovascular and neurological disorders, rising geriatric population is anticipated to have a significant impact on the market. A patient’s susceptibility to infectious diseases rises as they age as their immune system becomes weaker.

Segmentation

By Product

The market is divided into reagents, instruments, and software. In the global market, the reagents segment accounted for the largest revenue share in 2022 owing to the extensive use of chemicals during testing. The COVID-19 testing programmes, which confirm both positive and negative tests, are also increasing the number of reagents used. For instance, SRL Inc. announced the launch of a new laboratory company named “IVD and COVID-19 testing” in February 2022. This service is intended to precisely confirm negative findings. The increase in PCR instrument installation for SARS-CoV-2 tests led to a sharp increase in the instruments segment. Rapid innovation is increasingly being prioritised in efforts to gain a competitive edge. For instance, the FDA licensed the InspectIR COVID-19 Breathalyzer in April 2022 for quick testing in places like doctors’ offices and mobile testing facilities.

By Technology

The market is divided into microbiology, molecular diagnostics, immunoassay, and others. In 2022, the microbiology segment accounted for the highest revenue share due to the fact that molecular diagnostics are used for all major parasitic, bacterial, and viral diseases. These tests are more advanced and do not have the limitations of conventional testing methods, such as irregular microbe growth in manually created media, extended turnaround times, and low sensitivity. The immunoassay technology market is anticipated to grow gradually at a CAGR during the forecast period due to rise in the need for fast PoC tests, companies are concentrating on the development and commercialization of immunoassays for COVID-19 diagnosis. For instance, in October 2020 Creative Diagnostics released SARS-CoV-2 immunoassay kits for the detection of SARS-CoV-2 antigens and antibodies.

By Application

The market is segregated into VRE, MRSA, clostridium difficile, respiratory virus, HIV, CRE, hepatitis B, candida, covid-19, chlamydia, gonorrhea, streptococcus, and others. In the global market, the covid-19 segment accounted for the largest revenue share in 2022 owing to the increasing use of SARS-CoV-2 testing to prevent the infection’s transmission. Along with the introduction of novel products, government programmes to improve public testing have also been one of the key factors in the segment’s growth. Improved testing is responsible for the rapid expansion of the TB and HIV categories. The development of novel diagnostic technologies that enable for testing of SARS-CoV-2 as well as influenza with discrimination between the two conditions to speed treatment has also increased the pace of influenza testing in the respiratory virus segment.

By Test Location

The market is segmented into central laboratories, point of care, and others. In 2022, the central laboratories segment accounted for the largest revenue share owing to the fact that laboratory-based tests guarantee greater accuracy, when compared to point of care diagnostics. The availability of complex tests that cannot be performed in PoC and homecare settings is another advantage. Additionally, the availability of procedures that enable home sample collection and lab testing makes testing extremely simple for patients. For instance, LabCorp’s home collection kit that enables simultaneous testing for the flu and SARS-CoV-2 gained EUA from the FDA in October 2021. The demand for point-of-care diagnostics has increased due to the growing demand for faster response times. The COVID-19 has promoted segment growth and increased demand for these products. Products in this market segment have a competitive advantage due to their quick turnaround time and lack of complexity.

Regional Markets

In 2022, North America region accounted for the highest revenue in the infectious disease in vitro diagnostics market and is expected to maintain its dominance during the forecast period. This is attributed to the existence of a supportive and flexible regulatory framework, the presence of significant industry players, and the emphasis on enhancing disease surveillance by performing additional tests. The Asia Pacific region to exhibit the greatest CAGR due to rising incidence of infectious diseases. The region’s growth is also being supported by the expanding access to healthcare in developing countries like India. The growing geriatric population in countries including Japan is another factor driving the use of IVD tests.

Competitor Insights

Some of the key players operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche, Ltd., OraSure Technologies, Inc., bioMérieux SA, BD, Danaher, Quidel Corp., Hologic, Inc. (Gen-Probe), Siemens Healthineers AG, QIAGEN, Abbott, and Bio-Rad Laboratories, Inc.

To achieve a competitive edge, these businesses are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Quest Diagnostics and Memorial Hermann Health System collaborated in January 2020 to enhance, cost-effectively deliver high-quality, novel diagnostic services for 21 hospital laboratories in the Huston region. The industry is predicted to grow as a result of such initiatives by major companies to increase their position.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, technology, application, and test location from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 113,752.1 Million
CAGR
  • 7.55%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Product
  • Technology
  • Application
  • Test Location
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Infectious Disease In Vitro Diagnostics Market Report 2022 – 2033

Product (Revenue, USD Million), 2022 – 2033

  • Reagents
  • Instruments
  • Software

Technology (Revenue, USD Million), 2022 – 2033

  • Microbiology
  • Molecular Diagnostics
  • Immunoassay
  • Others

Application (Revenue, USD Million), 2022 – 2033

  • VRE
  • MRSA
  • Clostridium Difficile
  • Respiratory Virus
  • HIV
  • CRE
  • Hepatitis B
  • Candida
  • Covid-19
  • Chlamydia
  • Gonorrhea
  • Streptococcus
  • Others

Test Location (Revenue, USD Million), 2022 – 2033

  • Central Laboratories
  • Point of Care
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Infectious Disease In Vitro Diagnostics Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Infectious Disease In Vitro Diagnostics
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Infectious Disease In Vitro Diagnostics Market  
  3. Market Analysis by Product
    1. Reagents
      1. Reagents Market Forecast, 2022-2033(USD Million)
    2. Instruments
      1. Instruments Market Forecast, 2022-2033(USD Million)
    3. Software
      1. Software Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Technology
    1. Microbiology
      1. Microbiology Market Forecast, 2022-2033(USD Million)
    2. Molecular Diagnostics
      1. Molecular Diagnostics Market Forecast, 2022-2033(USD Million)
    3. Immunoassay
      1. Immunoassay Market Forecast, 2022-2033(USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Application  
    1. VRE
      1. VRE Market Forecast, 2022-2033(USD Million)
    2. MRSA
      1. MRSA Market Forecast, 2022-2033(USD Million)
    3. Clostridium Difficile
      1. Clostridium Difficile Market Forecast, 2022-2033(USD Million)
    4. Respiratory Virus
      1. Respiratory Virus Market Forecast, 2022-2033(USD Million)
    5. HIV
      1. HIV Market Forecast, 2022-2033(USD Million)
    6. CRE
      1. CRE Market Forecast, 2022-2033(USD Million)
    7. Hepatitis B
      1. Hepatitis B Market Forecast, 2022-2033(USD Million)
    8. Candida
      1. Candida Market Forecast, 2022-2033(USD Million)
    9. Covid-19
      1. Covid-19 Market Forecast, 2022-2033(USD Million)
    10. Chlamydia
      1. Chlamydia Market Forecast, 2022-2033(USD Million)
    11. Gonorrhea
      1. Gonorrhea Market Forecast, 2022-2033(USD Million)
    12. Streptococcus
      1. Streptococcus Market Forecast, 2022-2033(USD Million)
    13. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Test Location
    1. Central Laboratories
      1. Central Laboratories Market Forecast, 2022-2033(USD Million)
    2. Point of Care
      1. Point of Care Market Forecast, 2022-2033(USD Million)
    3. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North AmericaInfectious Disease In Vitro Diagnostics Market   
    1. North AmericaInfectious Disease In Vitro Diagnostics Market  
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
        3. Market Size and Forecast by Application, 2022-2033(USD Million)
        4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
      2. S.Infectious Disease In Vitro Diagnostics Market  
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
          3. Market Size and Forecast by Application, 2022-2033(USD Million)
          4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
        2. CanadaInfectious Disease In Vitro Diagnostics Market  
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
            3. Market Size and Forecast by Application, 2022-2033(USD Million)
            4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
  1. EuropeInfectious Disease In Vitro Diagnostics Market   
    1. EuropeInfectious Disease In Vitro Diagnostics Market  
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
        3. Market Size and Forecast by Application, 2022-2033(USD Million)
        4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
      2. GermanyInfectious Disease In Vitro Diagnostics Market  
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
          3. Market Size and Forecast by Application, 2022-2033(USD Million)
          4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
        2. UKInfectious Disease In Vitro Diagnostics Market  
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
            3. Market Size and Forecast by Application, 2022-2033(USD Million)
            4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
          2. FranceInfectious Disease In Vitro Diagnostics Market  
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
              3. Market Size and Forecast byApplication, 2022-2033 (USD Million)
              4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
            2. SpainInfectious Disease In Vitro Diagnostics Market  
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                3. Market Size and Forecast by Application, 2022-2033(USD Million)
                4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
              2. ItalyInfectious Disease In Vitro Diagnostics Market  
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Product, 2022-2033(USD Million)
                  2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Application, 2022-2033(USD Million)
                  4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
                2. Rest of EuropeInfectious Disease In Vitro Diagnostics Market  
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Product, 2022-2033(USD Million)
                    2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Application, 2022-2033(USD Million)
                    4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
  1. Asia PacificInfectious Disease In Vitro Diagnostics Market   
    1. Asia PacificInfectious Disease In Vitro Diagnostics Market  
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
        3. Market Size and Forecast by Application, 2022-2033(USD Million)
        4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
      2. JapanInfectious Disease In Vitro Diagnostics Market  
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
          3. Market Size and Forecast by Application, 2022-2033(USD Million)
          4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
        2. ChinaInfectious Disease In Vitro Diagnostics Market  
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
            3. Market Size and Forecast by Application, 2022-2033(USD Million)
            4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
          2. IndiaInfectious Disease In Vitro Diagnostics Market  
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
              3. Market Size and Forecast by Application, 2022-2033(USD Million)
              4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
            2. South KoreaInfectious Disease In Vitro Diagnostics Market  
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                3. Market Size and Forecast by Application,2022-2033 (USD Million)
                4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
              2. AustraliaInfectious Disease In Vitro Diagnostics Market  
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Product, 2022-2033(USD Million)
                  2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Application 2022-2033(USD Million)
                  4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
                2. Rest of Asia PacificInfectious Disease In Vitro Diagnostics Market  
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Product, 2022-2033(USD Million)
                    2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Application, 2022-2033(USD Million)
                    4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
  1. Latin America Infectious Disease In Vitro Diagnostics Market   
    1. Latin AmericaInfectious Disease In Vitro Diagnostics Market  
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
        3. Market Size and Forecast by Application, 2022-2033(USD Million)
        4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
      2. BrazilInfectious Disease In Vitro Diagnostics Market  
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Application, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
          3. Market Size and Forecast by Application, 2022-2033(USD Million)
          4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
        2. MexicoInfectious Disease In Vitro Diagnostics Market  
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
            3. Market Size and Forecast by Application, 2022-2033(USD Million)
            4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
          2. ArgentinaInfectious Disease In Vitro Diagnostics Market  
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
              3. Market Size and Forecast by Application, 2022-2033(USD Million)
              4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
            2. Rest of Latin AmericaInfectious Disease In Vitro Diagnostics Market  
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
                3. Market Size and Forecast by Application, 2022-2033(USD Million)
                4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
  1. MEAInfectious Disease In Vitro Diagnostics Market   
    1. MEAInfectious Disease In Vitro Diagnostics Market  
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
        3. Market Size and Forecast by Application, 2022-2033(USD Million)
        4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
      2. GCCInfectious Disease In Vitro Diagnostics Market  
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
          3. Market Size and Forecast by Application, 2022-2033(USD Million)
          4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
        2. South AfricaInfectious Disease In Vitro Diagnostics Market  
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
            3. Market Size and Forecast by Application, 2022-2033(USD Million)
            4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
          2. Rest of MEAInfectious Disease In Vitro Diagnostics Market  
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
              3. Market Size and Forecast by Application, 2022-2033(USD Million)
              4. Market Size and Forecast byTest Location, 2022-2033 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Hoffmann-La Roche, Ltd.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. OraSure Technologies, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. bioMérieux SA
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. BD
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Danaher
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Quidel Corp.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Hologic, Inc. (Gen-Probe)
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Siemens Healthineers AG
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. QIAGEN
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Abbott
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Bio-Rad Laboratories, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.